comparing the aquios cl flow cytometer, …...white paperwhite paper the comparability of the aquios...

4
WHITE PAPER The comparability of the AQUIOS Tetra System was assessed by comparing the results with the predicate method using the estimation of difference as described in CLSI EP9-A3 Method Comparison and Bias Estimation Using Patient Samples. For CD3+, CD3+/CD4+, CD3+/CD8+, CD3-/(CD56+CD16+), and CD3-CD19+, the comparator method is samples stained with MultiTEST CD3-FITC/CD8-PE/CD45-PerCP/CD4-APC and MultiTEST CD3- FITC/CD16+CD56-PE/CD45-PerCP/CD19-APC monoclonal antibody reagents run on a BD FACSCalibur Flow Cytometer with MultiTEST 4-color TBNK software. For CD45+ and CD45+ Low SS, the comparator method is specimens run on a UniCel DxH 800 hematology analyzer. Both method comparisons are comprised of 78% clinical specimens and 22% normal specimens. The data in Figure 1 through Figure 8 supports the premise that the systems are equivalent in their performance enumerating mature T, B, and NK lymphocytes in peripheral whole blood. Values are expressed in terms of percentage (%) of the total lymphocyte count and as absolute count (cells/µL) for CD3+, CD3+/CD4+, CD3+/CD8+, CD3-/CD19+, and CD3-/CD56+ CD16+ cells as well as percentage (%) of CD45+ Low SS and absolute count (cells/µL) for CD45+ and CD45+Low SS when analyzed using Tetra Combo analytical mode. Table 1. Method Comparison Between the AQUIOS Tetra Application and the BD FACSCalibur AQUIOS TETRA-1 PANEL CD45-FITC/CD4-RD1/CD8-ECD/CD3-PC5 (N=443) Mean BD FACSCalibur™ Mean AQUIOS Tetra Correlation Slope Intercept % + Lymphocytes CD3+ 71.64 71.75 0.986 0.963 2.786 CD3+/CD4+ 31.11 31.26 0.996 0.997 0.228 CD3+/CD8+ 38.59 38.16 0.955 0.983 0.210 Cells/µL CD3+ 1146 1118 0.977 0.978 10.453 CD3+/CD4+ 514 499 0.986 0.984 2.657 CD3+/CD8+ 603 582 0.982 0.965 4.689 AQUIOS TETRA-2+ PANEL CD45-FITC/CD56+CD16-RD1/CD19-ECD/CD3-PC5 (N=443) % + Lymphocytes CD3+ 71.65 71.93 0.987 0.970 2.433 CD3-/CD19+ 14.01 13.61 0.987 0.990 -0.260 CD3-/CD56+CD16+ 12.93 13.18 0.986 0.998 0.278 Cells/µL CD3+ 1166 1106 0.973 0.950 9.643 CD3-/CD19+ 226 207 0.975 0.873 9.665 CD3-/CD56+CD16+ 190 181 0.979 0.966 2.756 COMPARING THE AQUIOS CL FLOW CYTOMETER, THE FACSCALIBUR FLOW CYTOMETER, AND THE UNICEL DXH 800 HEMATOLOGY ANALYZER TETRA APPLICATIONS

Upload: others

Post on 28-May-2020

3 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: COMPARING THE AQUIOS CL FLOW CYTOMETER, …...WHITE PAPERWHITE PAPER The comparability of the AQUIOS Tetra System was assessed by comparing the results with the predicate method using

WHITE PAPERWHITE PAPER

The comparability of the AQUIOS Tetra System was assessed by comparing the results with the predicate method using the estimation of difference as described in CLSI EP9-A3 Method Comparison and Bias Estimation Using Patient Samples. For CD3+, CD3+/CD4+, CD3+/CD8+, CD3-/(CD56+CD16+), and CD3-CD19+, the comparator method is samples stained with MultiTEST™ CD3-FITC/CD8-PE/CD45-PerCP/CD4-APC and MultiTEST™ CD3-FITC/CD16+CD56-PE/CD45-PerCP/CD19-APC monoclonal antibody reagents run on a BD FACSCalibur™ Flow Cytometer with MultiTEST™ 4-color TBNK software.

For CD45+ and CD45+ Low SS, the comparator method is specimens run on a UniCel DxH 800 hematology analyzer. Both method comparisons are comprised of 78% clinical specimens and 22% normal specimens. The data in Figure 1 through Figure 8 supports the premise that the systems are equivalent in their performance enumerating mature T, B, and NK lymphocytes in peripheral whole blood.

Values are expressed in terms of percentage (%) of the total lymphocyte count and as absolute count (cells/µL) for CD3+, CD3+/CD4+, CD3+/CD8+, CD3-/CD19+, and CD3-/CD56+ CD16+ cells as well as percentage (%) of CD45+ Low SS and absolute count (cells/µL) for CD45+ and CD45+Low SS when analyzed using Tetra Combo analytical mode.

Table 1. Method Comparison Between the AQUIOS Tetra Application and the BD FACSCalibur™

AQUIOS TETRA-1 PANEL CD45-FITC/CD4-RD1/CD8-ECD/CD3-PC5 (N=443)

Mean BD FACSCalibur™ Mean AQUIOS Tetra Correlation Slope Intercept

% + Lymphocytes

CD3+ 71.64 71.75 0.986 0.963 2.786

CD3+/CD4+ 31.11 31.26 0.996 0.997 0.228

CD3+/CD8+ 38.59 38.16 0.955 0.983 0.210

Cells/µL

CD3+ 1146 1118 0.977 0.978 10.453

CD3+/CD4+ 514 499 0.986 0.984 2.657

CD3+/CD8+ 603 582 0.982 0.965 4.689

AQUIOS TETRA-2+ PANEL CD45-FITC/CD56+CD16-RD1/CD19-ECD/CD3-PC5 (N=443)

% + Lymphocytes

CD3+ 71.65 71.93 0.987 0.970 2.433

CD3-/CD19+ 14.01 13.61 0.987 0.990 -0.260

CD3-/CD56+CD16+ 12.93 13.18 0.986 0.998 0.278

Cells/µL

CD3+ 1166 1106 0.973 0.950 9.643

CD3-/CD19+ 226 207 0.975 0.873 9.665

CD3-/CD56+CD16+ 190 181 0.979 0.966 2.756

COMPARING THE AQUIOS CL FLOW CYTOMETER, THE FACSCALIBUR™ FLOW CYTOMETER, AND THE UNICEL DXH 800 HEMATOLOGY ANALYZER TETRA APPLICATIONS

Page 2: COMPARING THE AQUIOS CL FLOW CYTOMETER, …...WHITE PAPERWHITE PAPER The comparability of the AQUIOS Tetra System was assessed by comparing the results with the predicate method using

Visualize the Possibilities

Table 2. Method Comparison Between the AQUIOS Tetra Application and the UniCel DxH 800

AQUIOS TETRA-1 PANEL CD45-FITC/CD4-RD1/CD8-ECD/CD3-PC5 (N=445)

Mean UniCel DxH 800 Mean AQUIOS Tetra Correlation Slope Intercept

%

CD45+ Low SS 27.60 27.49 0.995 0.999 -0.084

Cells/µL

CD45+ 6131 5991 0.992 0.985 -51.430

CD45+ Low SS 1583 1537 0.993 0.977 -6.156

AQUIOS Tetra-1 Panel CD45-FITC/CD4-RD1/CD8-ECD/CD3-PC5

Figure 1. Regression Analysis for the CD3+ Cells using the AQUIOS Tetra Application and the BD FACSCalibur™

Figure 2. Regression Analysis for the CD3+/CD4+ Cells using the AQUIOS Tetra Application and the BD FACSCalibur™

Figure 3. Regression Analysis for the CD3+/CD8+ Cells using the AQUIOS Tetra Application and the BD FACSCalibur™

Reference

Tes

tT

est

Tes

t

Tes

tT

est

Tes

t

Reference

Reference

Reference

Reference

Reference

Page 3: COMPARING THE AQUIOS CL FLOW CYTOMETER, …...WHITE PAPERWHITE PAPER The comparability of the AQUIOS Tetra System was assessed by comparing the results with the predicate method using

Visualize the Possibilities

Figure 4. Regression Analysis for the CD45+ Cells using the AQUIOS Tetra Application and the UniCel DxH 800

Figure 5. Regression Analysis for the CD45+ Low SS Cells using the AQUIOS Tetra Application and the UniCel DxH 800

AQUIOS Tetra-2+ Panel CD45-FITC/(CD56+CD16)-RD1/CD19-ECD/CD3-PC5

Figure 6. Regression Analysis for the CD3+ Cells using the AQUIOS Tetra Application and the BD FACSCalibur™

Tes

tT

est

Tes

t

Tes

tT

est

Reference

Reference

Reference

Reference

Reference

Page 4: COMPARING THE AQUIOS CL FLOW CYTOMETER, …...WHITE PAPERWHITE PAPER The comparability of the AQUIOS Tetra System was assessed by comparing the results with the predicate method using

Figure 7. Regression Analysis for the CD3-/CD19+ Cells using the AQUIOS Tetra Application and the BD FACSCalibur™

Figure 8. Regression Analysis for the CD3-/CD56+CD16+ Cells using the AQUIOS Tetra Application and the BD FACSCalibur™

ConclusionsThe data demonstrates substantial equivalence of the AQUIOS CL Flow Cytometer to the FACSCalibur™ Flow Cytometer and the UniCel DxH 800 Hematology Analyzer.

Note: The cleared parameters of CD45 and CD45 low Side Scatter were not directly compared to the FACSCalibur™ Flow Cytometer since these parameters do not currently appear in the FACSCalibur™ Flow Cytometer intended use statement.

AQUIOS CL is a Class I Laser Product.

For Beckman Coulter’s worldwide office locations and phone numbers, please visit “Contact Us” at beckmancoulter.com

FLOW-1131WP10.15-A

Beckman Coulter, the stylized logo, and the Beckman Coulter product and service used herein are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries.

Tes

tT

est

Tes

tT

est

Reference

Reference

Reference

Reference